SEC Form 4 · accession 0001225208-19-003009
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine M. Szyman
Officer — CVP, Critical Care
Period of report
Feb 19, 2019
Accepted (ET)
Feb 19, 2019 · 8:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2019 | F | 697 | $177.78 | D | 25,974 | D | |
| Common Stock | Feb 19, 2019 | F | 2,227 | $177.78 | D | 23,747 | D | |
| Common Stock | holding | — | — | — | 2,630 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.